OPRM1 A118G and serum β-endorphin interact with sex and digit ratio (2D:4D) to influence risk and course of alcohol dependence

Eur Neuropsychopharmacol. 2018 Dec;28(12):1418-1428. doi: 10.1016/j.euroneuro.2018.09.002. Epub 2018 Oct 12.

Abstract

Activation of mesolimbic mu-opioid receptors by their endogenous ligand, β-endorphin, can mediate the rewarding effects of alcohol. However, there is conflicting evidence on the relationship between the mu-opioid receptor (OPRM1) A118G single nucleotide polymorphism (SNP) and alcohol dependence risk. Preclinical evidence suggests that sex and sex hormone-dependent prenatal brain organization may interact with the opioid system to influence alcohol drinking behavior. We genotyped 200 alcohol-dependent patients and 240 healthy individuals for the OPRM1 A118G SNP and measured serum β-endorphin level at recruitment and after acute withdrawal. We then determined the association between these factors and alcohol dependence risk and 24-month outcome in the context of both sex and second-to-fourth digit lengths ratio (2D:4D) - a biomarker of prenatal sex hormone levels. The OPRM1 A118G AA genotype associated with elevated risk of alcohol-related hospital readmission, more readmissions, and fewer days until first readmission in male patients only. After normalizing patient 2D:4D against control 2D:4D, we found that normalized 2D:4D ratios were lower in male 118G patients than male AA patients, suggesting prenatal androgens interact with OPRM1 to influence alcohol dependence risk. In addition, β-endorphin levels after acute withdrawal correlated negatively with withdrawal severity in females but not in males, which may indicate β-endorphin protects against withdrawal-induced stress in a sex-specific manner.

Keywords: 2D:4D; A118G; Alcohol dependence; OPRM1; Prenatal androgens; β-endorphin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Alcohol Drinking / genetics
  • Alcohol Drinking / pathology
  • Alcohol Drinking / physiopathology
  • Alcohol Drinking / therapy
  • Alcoholism / genetics*
  • Alcoholism / pathology
  • Alcoholism / physiopathology*
  • Alcoholism / therapy
  • Androgens / metabolism
  • Cohort Studies
  • Female
  • Fingers / pathology*
  • Genetic Association Studies
  • Genetic Predisposition to Disease
  • Genotype
  • Humans
  • Male
  • Middle Aged
  • Organ Size
  • Patient Admission
  • Polymorphism, Single Nucleotide
  • Pregnancy
  • Prenatal Exposure Delayed Effects
  • Receptors, Opioid, mu / genetics*
  • Sex Characteristics*
  • Treatment Outcome
  • beta-Endorphin / blood*

Substances

  • Androgens
  • OPRM1 protein, human
  • Receptors, Opioid, mu
  • beta-Endorphin